首页> 外国专利> ANTI-BFGF HUMANIZED DOUBLE-STRANDED ANTIBODY WITH STABLE DISULFIDE BOND, PREPARATION METHOD AND APPLICATION THEREOF

ANTI-BFGF HUMANIZED DOUBLE-STRANDED ANTIBODY WITH STABLE DISULFIDE BOND, PREPARATION METHOD AND APPLICATION THEREOF

机译:具有稳定二硫键的抗BFGF人源化双链抗体,制备方法及其应用

摘要

Disclosed are an anti-bFGF humanized double-stranded antibody with stable disulfide bond, preparation method and applications thereof. The amino acid sequence of the anti-bFGF humanized double-stranded antibody is shown in SEQ ID NO.1. The nucleotide sequence of gene encoding the anti-bFGF humanized double-stranded antibody is shown in SEQ ID NO.2. By site-directed mutation, one cysteine residue is introduced into each single-stranded antibody, thus introduce the disulfide bond and form ds-Diabody. It is shown by experiments that the obtained ds-Diabody has the following advantages: enhanced stability; better affinity when binding to the specific antigen bFGF; moderate relative molecular weight, good tumor targeting, approved tumor tissue penetrating power, and higher blood clearance rate, showing a broad application prospects in the clinic diagnosis and medical treatment.
机译:本发明公开了一种具有稳定二硫键的抗bFGF人源化双链抗体及其制备方法和应用。抗bFGF人源化双链抗体的氨基酸序列示于SEQ ID NO.1。编码抗bFGF人源化双链抗体的基因的核苷酸序列示于SEQ ID NO.2。通过定点突变,将一个半胱氨酸残基引入每个单链抗体中,从而引入二硫键并形成ds-Diabody。实验表明,所得ds-Diabody具有以下优点:稳定性增强;与特异性抗原bFGF结合时具有更好的亲和力;相对分子量适中,良好的肿瘤靶向性,批准的肿瘤组织穿透力,较高的血液清除率,在临床诊断和医学治疗中具有广阔的应用前景。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号